Deutsche Bank’s Traws Pharma TRAW Stock Holding History

Deutsche Bank’s Portfolio TRAW Stock Details TRAW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-654	Closed	-$113K	–	4714
2021 Q2	$113K	Buy	+654	New	+$148K	﹤0.01%	4090
2018 Q4	–	Sell	-1	Closed	-$2K	–	5458
2018 Q3	$2K	Buy	+1	New	+$2.55K	﹤0.01%	5259
2016 Q3	–	Hold	0	–	-$14K	–	5234
2016 Q2	–	Sell	-1	Closed	-$28.1K	–	4847
2016 Q1	$20K	Buy	+1	New	+$31.7K	﹤0.01%	4638
2015 Q4	–	Hold	0	–	–	–	5205
2015 Q3	–	Hold	0	–	–	–	5366
2015 Q2	–	Hold	0	–	–	–	5183
2015 Q1	–	Sell	-1	Closed	-$164K	–	4675
2014 Q4	$135K	Buy	+1	New	+$245K	﹤0.01%	4523
2014 Q3	–	Hold	0	–	–	–	5269
2014 Q2	–	Hold	0	–	–	–	4753
2014 Q1	–	Sell	-1	Closed	-$602K	–	4786
2013 Q4	$569K	Hold	1	–	–	﹤0.01%	3014
2013 Q3	$1.51M	Buy	+1	New	+$1.43M	﹤0.01%	2669

Other funds holding TRAW

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Alyeska Investment Group Chicago, Illinois $38.9B AUM 28.51% 1-Year Est. Return

GSA Capital Partners London, United Kingdom $1.59B AUM 39.8% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

Hudson Bay Capital Management Stamford, Connecticut $36.8B AUM 42.13% 1-Year Est. Return

Pura Vida Investments New York $37M AUM 63.54% 1-Year Est. Return

CVI Holdings Wilmington, Delaware $116M AUM 5.68% 1-Year Est. Return

Walleye Capital New York $28B AUM 44.22% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

Deutsche Bank's TRAW Position: Q3 2021 in Review

Deutsche Bank sold out of Traws Pharma (TRAW) in Q3 2021, closing a stake of 654 shares — an estimated $113K sold.

Deutsche Bank first reported a position in TRAW in Q3 2013 and held it in 6 quarters. The position peaked at $1.51M in Q3 2013. 34 funds tracked by Wall St. Rank hold TRAW as of Q3 2021.

Deutsche Bank reported no remaining Traws Pharma position as of Q3 2021 after selling out during the quarter.
Deutsche Bank sold 654 Traws Pharma shares in Q3 2021, an estimated $113K.
Deutsche Bank first reported a position in Traws Pharma in Q3 2013 and held it in 6 quarters.
Deutsche Bank's Traws Pharma position peaked at $1.51M in Q3 2013.
34 funds tracked by Wall St. Rank held Traws Pharma as of Q3 2021.

Based on Deutsche Bank's 13F filing for Q3 2021, filed 4 Nov 2021.